PCIA
PRME icon

Prime Capital Investment Advisors’s Prime Medicine PRME Stock Holding History

Prime Capital Investment Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8K Hold
12,945
– – ﹤0.01% 1066
2026
Q1 		$45K Sell
12,945
-1,110
-8% -$4.22K ﹤0.01% 1023
2025
Q4 		$48.8K Sell
14,055
-324
-2% -$1.44K ﹤0.01% 1002
2025
Q3 		$79.7K Sell
14,379
-1,652
-10% -$6.71K ﹤0.01% 975
2025
Q2 		$39.6K Sell
16,031
-8,230
-34% -$12.7K ﹤0.01% 933
2025
Q1 		$48.3K Buy
24,261
+306
+1% +$781 ﹤0.01% 1028
2024
Q4 		$69.9K Buy
+23,955
New +$84.1K ﹤0.01% 903

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Prime Capital Investment Advisors's PRME Position: Q2 2026 in Review

Prime Capital Investment Advisors held its Prime Medicine (PRME) position steady in Q2 2026 at 12,945 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

Prime Capital Investment Advisors first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. The position peaked at $79.7K in Q3 2025. 123 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Prime Capital Investment Advisors held 12,945 shares of Prime Medicine worth $47.8K as of Q2 2026.
  • Prime Capital Investment Advisors left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #1066 holding.
  • Prime Capital Investment Advisors first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • Prime Capital Investment Advisors's Prime Medicine position peaked at $79.7K in Q3 2025.
  • 123 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.